
    
      -  Screening: 7 to 10 days

        -  Treatment period: 14 days (Period 1: 7 days; Period 2: 7 days)

        -  End of study: 7 days after the last dosing,

        -  Total duration from screening per subject: 22 to 25 days.
    
  